Cedars-Sinai investigators, leading a multi-institutional team, have developed and validated a tool to predict which patients ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

An off-the-shelf cancer vaccine is associated with durable responses and a reduced risk of relapse and death among patients with pancreatic or colorectal cancers. An off-the-shelf cancer vaccine has ...

In an early trial, a one-size-fits-all vaccine showed promise in preventing hard-to-treat pancreatic cancers from coming back. Pancreatic cancer is of particular concern. The five-year survival rate ...

Chemotherapy and supportive care practice patterns among older adults with metastatic pancreatic cancer.

Research shows that gastrointestinal cancers — including stomach, liver, esophageal, pancreatic, and colorectal cancers — account for about 26% of all cancers worldwide and 35% of all cancer-related ...

In a significant development for pancreatic cancer treatment, a phase 1 clinical trial has highlighted the potential of ...

Please provide your email address to receive an email when new articles are posted on . Vaccine could improve survival for patients with pancreatic and colorectal cancers. Vaccine targets mutant KRAS ...

Autonomix's targeted ablation therapy improved symptoms, functionality, and quality of life in severe pancreatic cancer patients, especially those with stage 4 disease. Rapid pain relief and durable ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of ...